StreetInsider.com  Sep 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+Pharma+%28TSPT%29%2C+SNBL+Enter+Terminate+Agreement/9851399.html for the full story.
StreetInsider.com  Jul 1  Comment 
Transcept Pharma (Nasdaq: TSPT) 23.6% HIGHER; Transcept Pharma and Paratek Pharmaceuticals, Inc., a privately-held biopharmaceutical company, announced that they have entered into a definitive merger agreement under which the stockholders of...
StreetInsider.com  Mar 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Transcept+Pharmaceuticals%2C+Inc.+%28TSPT%29+Posts+Q4+Loss+of+29cShare/9280288.html for the full story.
StreetInsider.com  Dec 17  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+Pharma+%28TSPT%29+Didn%27t+See+Retrophin+Offer+as+%27Bonafide%27/8987405.html for the full story.
StreetInsider.com  Dec 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+Pharma+%28TSPT%29+Notes+ISS+Support+Against+Stockholder+Group/8970551.html for the full story.
StreetInsider.com  Nov 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+Pharma+%28TSPT%29+to+Eliminate+43%25+of+Workforce%3B+Will+Explore+Options/8879167.html for the full story.
StreetInsider.com  Sep 30  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+Pharma+%28TSPT%29+Responds+to+Request+by+Retrophin+to+Acquire+Up+to+15%25+Stake/8731035.html for the full story.
StreetInsider.com  Sep 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+%28TSPT%29%2C+Shin+Nippon+Enter+Acute+Migraine+Treatment+Licensing+Agreement/8721346.html for the full story.
StreetInsider.com  Sep 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+Pharma+%28TSPT%29+Rejects+%244Share+Offer/8721280.html for the full story.
StreetInsider.com  Sep 19  Comment 
* Agilent Technologies Inc. (NYSE: A) today announced plans to separate into two publicly traded companies: one in life sciences, diagnostics and applied markets (LDA) that will retain the Agilent name, and the other that will be comprised of...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki